GlucoTrack, Inc. (GCTK)

NASDAQ: GCTK · IEX Real-Time Price · USD
0.307
+0.007 (2.33%)
At close: Mar 1, 2024, 4:00 PM
0.315
+0.008 (2.61%)
After-hours: Mar 1, 2024, 7:57 PM EST
2.33%
Market Cap 7.52M
Revenue (ttm) n/a
Net Income (ttm) -4.80M
Shares Out 24.49M
EPS (ttm) -0.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 273,736
Open 0.291
Previous Close 0.300
Day's Range 0.291 - 0.318
52-Week Range 0.133 - 3.750
Beta 0.16
Analysts n/a
Price Target n/a
Earnings Date n/a

About GCTK

GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Isra... [Read more]

Sector Healthcare
Founded 2001
Employees 3
Stock Exchange NASDAQ
Ticker Symbol GCTK
Full Company Profile

Financial Performance

Financial Statements

News

GLUCOTRACK SELECTS CIRTEC MEDICAL AS MANUFACTURER FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR

Rutherford, NJ & Brooklyn Park, MN, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization of novel techn...

5 days ago - GlobeNewsWire

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF LUIS MALAVÉ TO CHAIR OF THE BOARD OF DIRECTORS

Rutherford, NJ, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of...

19 days ago - GlobeNewsWire

GLUCOTRACK ANNOUNCES EARLY ACCURACY DATA FOR ITS IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Rutherford, NJ, Jan. 02, 2024 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device company focused on the design, development, and commercialization of...

2 months ago - GlobeNewsWire

GLUCOTRACK ANNOUNCES 180-DAY EXTENSION TO REGAIN COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT

Rutherford, NJ, Nov. 30, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with d...

3 months ago - GlobeNewsWire

GLUCOTRACK ANNOUNCES SHAREHOLDER UPDATE

Rutherford, NJ, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with d...

3 months ago - GlobeNewsWire

GLUCOTRACK ANNOUNCES PRECLINICAL TESTING WITH IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Rutherford, NJ, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with d...

5 months ago - GlobeNewsWire

GLUCOTRACK ANNOUNCES THE APPOINTMENT OF ERIN CARTER TO BOARD OF DIRECTORS

Rutherford, NJ, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with d...

6 months ago - GlobeNewsWire

GLUCOTRACK ANNOUNCES NEW VP OF MARKETING

Rutherford, NJ, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on glucose monitoring technologies for people with d...

6 months ago - GlobeNewsWire

GLUCOTRACK ANNOUNCES POSITIVE DATA FROM FEASIBILITY STUDY FOR IMPLANTABLE CONTINUOUS GLUCOSE MONITOR

Rutherford, NJ, July 25, 2023 (GLOBE NEWSWIRE) -- - Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device and digital health platform company focused on diabetes and predia...

7 months ago - GlobeNewsWire

Aegis Capital Corp. Acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for GlucoTrack, Inc. (NASDAQ: GCTK)

NEW YORK, NY / ACCESSWIRE / April 17, 2023 / Aegis Capital Corp. acted as Sole Bookrunner on a $10 Million Underwritten Public Offering for GlucoTrack, Inc. (NASDAQ:GCTK). About GlucoTrack, Inc. Gluco...

11 months ago - Accesswire

GlucoTrack Closes $10 Million Underwritten Public Offering of Common Stock

Rutherford, NJ, April 17, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediab...

11 months ago - GlobeNewsWire

GlucoTrack Announces Pricing of $10 Million Underwritten Public Offering of Common Stock

Rutherford, NJ, April 13, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediab...

11 months ago - GlobeNewsWire

GlucoTrack Announces Proposed Underwritten Public Offering of Common Stock

Rutherford, NJ, April 12, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediab...

11 months ago - GlobeNewsWire

GLUCOTRACK PROVIDES SHAREHOLDER UPDATE

Rutherford, NJ, March 14, 2023 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a medical device and digital health platform company focused on diabetes and prediab...

1 year ago - GlobeNewsWire

GLUCOTRACK ANNOUNCES THE HIRING OF DR. MARK TAPSAK

INDUSTRY VETERAN TO LEAD NEW CONTINUOUS GLUCOSE MONITORING R&D PROGRAM

1 year ago - GlobeNewsWire

GLUCOTRACK TO BEGIN RESEARCH & DEVELOPMENT OF NOVEL CONTINUOUS GLUCOSE MONITORING SYSTEM

Rutherford, NJ, Oct. 10, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a non-invasive device and digital health platform for measuring glucose levels in peo...

1 year ago - GlobeNewsWire

GlucoTrack, Inc. Provides Development Update on its Gen 2 Non-Invasive Glucose Monitor

Rutherford, NJ and Or Yehuda, Israel, June 22, 2022 (GLOBE NEWSWIRE) -- GlucoTrack, Inc. (Nasdaq: GCTK) (“GlucoTrack” or the “Company”), a non-invasive device and digital health platform for measuring...

1 year ago - GlobeNewsWire

GlucoTrack, Inc. Announces Effectiveness of Corporate Name Change and Ticker Symbol Change

To begin trading under the Nasdaq Symbol GCTK

2 years ago - GlobeNewsWire

Integrity Applications Issues Shareholder Update Letter

Wilmington, DE and Or Yehuda, Israel, Dec. 20, 2021 (GLOBE NEWSWIRE) --  Integrity Applications, Inc. (www.integrity-app.com) (NASDAQ: IGAP), innovator of GlucoTrack ® , a non-invasive device for meas...

2 years ago - GlobeNewsWire

Integrity Applications Announces Uplisting to Nasdaq Capital Market

Wilmington, DE and Or Yehuda, Israel, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack ® , a non-invasive device for measur...

2 years ago - GlobeNewsWire

Integrity Applications, Inc. Expands U.S. Operations with the hiring of James P. Thrower, PhD, as Vice President of Engineering

Wilmington, DE and Or Yehuda, Israel, Dec. 06, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack ®, a non-invasive device for measuri...

2 years ago - GlobeNewsWire

Integrity Applications Announces Name Change to GlucoTrack, Inc.

Wilmington, DE and Or Yehuda, Israel,, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack® , a non-invasive device for measur...

2 years ago - GlobeNewsWire

Integrity Applications Announces the Appointment of Paul V. Goode, PhD, as President and Chief Operating Officer

Wilmington, DE and Or Yehuda, Israel, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack ® , a non-invasive device for measur...

2 years ago - GlobeNewsWire

Integrity Applications, Inc. Announces Filing of Form S-3 Shelf Registration Statement

Wilmington, DE and Or Yehuda, Israel, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack ® , a non-invasive device for measu...

2 years ago - GlobeNewsWire

Integrity Applications, Inc. Implements Reverse Stock Split To Meet NASDAQ Initial Listing Requirements

Wilmington, DE and Ashdod, Israel, Aug. 12, 2021 (GLOBE NEWSWIRE) -- Integrity Applications, Inc. (www.integrity-app.com) (OTCQB: IGAP), innovator of GlucoTrack ®, a non-invasive device for measuring ...

2 years ago - GlobeNewsWire